Cargando…

Origin and role of hepatic myofibroblasts in hepatocellular carcinoma

Hepatocellular carcinoma (HCC) is the most common primary liver cancer and is the second leading cause of cancer-related death worldwide. Fibrosis and cirrhosis are important risk factors for the development of HCC. Hepatic myofibroblasts are the cells responsible for extracellular matrix deposition...

Descripción completa

Detalles Bibliográficos
Autores principales:	Yavuz, Betul Gok, Pestana, Roberto Carmagnani, Abugabal, Yehia I., Krishnan, Sunil, Chen, Jian, Hassan, Manal M., Wolff, Robert A., Rashid, Asif, Amin, Hesham M., Kaseb, Ahmed O.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Impact Journals LLC 2020
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7138168/ https://www.ncbi.nlm.nih.gov/pubmed/32284794 http://dx.doi.org/10.18632/oncotarget.27532

Ejemplares similares

Clinical and prognostic significance of circulating levels of angiopoietin-1 and angiopoietin-2 in hepatocellular carcinoma
por: Pestana, Roberto Carmagnani, et al.
Publicado: (2018)

Insulin-like growth factor 1/Child-Turcotte-Pugh composite score as a predictor of treatment outcomes in patients with advanced hepatocellular carcinoma treated with sorafenib
por: Mohamed, Yehia I., et al.
Publicado: (2021)

Blockade of growth hormone receptor signaling by using pegvisomant: A functional therapeutic strategy in hepatocellular carcinoma
por: Kaseb, Ahmed O., et al.
Publicado: (2022)

Prognostic Significance of Serum Insulin-Like Growth Factor-1 in Hepatocellular Cancer Patients: A Validation Study
por: Lacin, Sahin, et al.
Publicado: (2020)

The Gut Microbiome as a Biomarker and Therapeutic Target in Hepatocellular Carcinoma
por: Gok Yavuz, Betul, et al.
Publicado: (2023)

Current Landscape and Future Directions of Biomarkers for Immunotherapy in Hepatocellular Carcinoma
por: Gok Yavuz, Betul, et al.
Publicado: (2021)

Evaluating clinical and prognostic implications of Glypican-3 in hepatocellular carcinoma
por: Kaseb, Ahmed Omar, et al.
Publicado: (2016)

Validation of an IGF-CTP scoring system for assessing hepatic reserve in egyptian patients with hepatocellular carcinoma
por: Abdel-Wahab, Reham, et al.
Publicado: (2015)

Immunotherapy response evaluation with magnetic resonance elastography (MRE) in advanced HCC
por: Qayyum, Aliya, et al.
Publicado: (2019)

Plasma growth hormone is a potential biomarker of response to atezolizumab and bevacizumab in advanced hepatocellular carcinoma patients
por: Mohamed, Yehia I., et al.
Publicado: (2022)

Development and Validation of Insulin-like Growth Factor-1 Score to Assess Hepatic Reserve in Hepatocellular Carcinoma
por: Kaseb, Ahmed O., et al.
Publicado: (2014)

Disruption of Growth Hormone Receptor Signaling Abrogates Hepatocellular Carcinoma Development
por: Haque, Abedul, et al.
Publicado: (2022)

Serum IGF-1 Scores and Clinical Outcomes in the Phase III IMbrave150 Study of Atezolizumab Plus Bevacizumab versus Sorafenib in Patients with Unresectable Hepatocellular Carcinoma
por: Kaseb, Ahmed O, et al.
Publicado: (2022)

Nonalcoholic steatohepatitis-related hepatocellular carcinoma: is there a role for the androgen receptor pathway?
por: Ali, Mahmoud A, et al.
Publicado: (2017)

Hepatitis C virus-associated hepatocellular carcinoma as a second primary malignancy: exposing an overlooked presentation of liver cancer
por: Dandachi, Dima, et al.
Publicado: (2018)

Type I insulin-like growth factor as a liver reserve assessment tool in hepatocellular carcinoma
por: Abdel-Wahab, Reham, et al.
Publicado: (2015)

Origin of myofibroblasts in liver fibrosis
por: Brenner, David A, et al.
Publicado: (2012)

The Origin and Fate of Liver Myofibroblasts
por: Kim, Hyun Young, et al.
Publicado: (2023)

Analysis of histology-agnostic targets among soft tissue and bone sarcomas in the AACR GENIE database
por: Pestana, Roberto Carmagnani, et al.
Publicado: (2023)

Association of dietary fat intake and hepatocellular carcinoma among US adults
por: Moussa, Iman, et al.
Publicado: (2021)

Clinical and Prognostic Biomarker Value of Blood-Circulating Inflammatory Cytokines in Hepatocellular Carcinoma
por: Chamseddine, Shadi, et al.
Publicado: (2023)

Decoding myofibroblast origins in human kidney fibrosis
por: Kuppe, Christoph, et al.
Publicado: (2021)

Dietary Patterns and Hepatocellular Carcinoma Risk among US Adults
por: Moussa, Iman, et al.
Publicado: (2021)

Precision Oncology in Sarcomas: Divide and Conquer
por: Carmagnani Pestana, Roberto, et al.
Publicado: (2019)

Experimental systems to study the origin of the myofibroblast in peritoneal fibrosis
por: Padwal, Manreet, et al.
Publicado: (2016)

Phase II trial of bevacizumab and erlotinib as a second-line therapy for advanced hepatocellular carcinoma
por: Kaseb, Ahmed O, et al.
Publicado: (2016)

Origin of renal myofibroblasts in the model of unilateral ureter obstruction in the rat
por: Picard, Nicolas, et al.
Publicado: (2008)

Role of Wnt/β-catenin signaling in hepatocellular carcinoma, pathogenesis, and clinical significance
por: Khalaf, Ahmed M, et al.
Publicado: (2018)

A Randomized, Double-Blind, Placebo-Controlled, Multicenter Study to Evaluate the Safety and Efficacy of ThymoQuinone Formula (TQF) for Treating Outpatient SARS-CoV-2
por: Bencheqroun, Hassan, et al.
Publicado: (2022)

Welcome to Journal of Hepatocellular Carcinoma
por: Kaseb, Ahmed O
Publicado: (2015)

Precision Medicine Targeting FGFR2 Genomic Alterations in Advanced Cholangiocarcinoma: Current State and Future Perspectives
por: Zugman, Miguel, et al.
Publicado: (2022)

Post-registration experience of nivolumab in advanced hepatocellular carcinoma: an international study
por: Fessas, Petros, et al.
Publicado: (2020)

Baseline Apparent Diffusion Coefficient as a Predictor of Response to Liver-Directed Therapies in Hepatocellular Carcinoma
por: Niekamp, Andrew, et al.
Publicado: (2018)

The myofibroblast, multiple origins for major roles in normal and pathological tissue repair
por: Micallef, Ludovic, et al.
Publicado: (2012)

Genetic lineage tracing defines myofibroblast origin and function in the injured heart
por: Kanisicak, Onur, et al.
Publicado: (2016)

Editorial: charting the future of hepatocellular carcinoma publications
por: Kaseb, Ahmed Omar
Publicado: (2018)

Identification of novel therapeutic targets in the PI3K/AKT/mTOR pathway in hepatocellular carcinoma using targeted next generation sequencing
por: Janku, Filip, et al.
Publicado: (2014)

Immunotherapy in Hepatocellular Cancer Patients with Mild to Severe Liver Dysfunction: Adjunctive Role of the ALBI Grade
por: Pinato, David J., et al.
Publicado: (2020)

Inflammatory myofibroblastic tumor mimicking hepatocellular carcinoma with dense lipiodol uptake
por: Hong, Seong Woo, et al.
Publicado: (2013)

EndMT: New findings on the origin of myofibroblasts in endometrial fibrosis of intrauterine adhesions
por: Xu, Chengcheng, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_okd068p5g4u28cbhgcjpmrh8ql